Results
|
321.
|
|
|
322.
|
|
|
323.
|
|
|
324.
|
|
|
325.
|
Assessment of preclinical drug interactions of bedaquiline by a highly sensitive LC-ESI-MS/MS based bioanalytical method. [electronic resource] by
- Kotwal, Pankul
- Magotra, Asmita
- Dogra, Ashish
- Sharma, Sumit
- Gour, Abhishek
- Bhatt, Shipra
- Wazir, Priya
- Singh, Parvinder Pal
- Singh, Gurdarshan
- Nandi, Utpal
Producer: 20190408
In:
Journal of chromatography. B, Analytical technologies in the biomedical and life sciences vol. 1112
Availability: No items available.
|
|
326.
|
Clobetasol Propionate Is a Heme-Mediated Selective Inhibitor of Human Cytochrome P450 3A5. [electronic resource] by
- Wright, William C
- Chenge, Jude
- Wang, Jingheng
- Girvan, Hazel M
- Yang, Lei
- Chai, Sergio C
- Huber, Andrew D
- Wu, Jing
- Oladimeji, Peter O
- Munro, Andrew W
- Chen, Taosheng
Producer: 20200803
In:
Journal of medicinal chemistry vol. 63
Availability: No items available.
|
|
327.
|
Effect of coadministration of ketoconazole, a strong CYP3A4 inhibitor, on pharmacokinetics and tolerability of motesanib diphosphate (AMG 706) in patients with advanced solid tumors. [electronic resource] by
- Lorusso, Patricia
- Heath, Elisabeth I
- McGreivy, Jesse
- Sun, Yu-Nien
- Melara, Rebeca
- Yan, Lucy
- Malburg, Lisa
- Ingram, Megan
- Wiezorek, Jeffrey
- Chen, Li
- Pilat, Mary Jo
Producer: 20090113
In:
Investigational new drugs vol. 26
Availability: No items available.
|
|
328.
|
Ketoconazole and rifampin significantly affect the pharmacokinetics, but not the safety or QTc interval, of casopitant, a neurokinin-1 receptor antagonist. [electronic resource] by
- Johnson, Brendan M
- Adams, Laurel M
- Zhang, Ke
- Gainer, Shelby D
- Kirby, Lyndon C
- Blum, Robert A
- Apseloff, Glen
- Morrison, Royce A
- Schutz, Ralph A
- Lebowitz, Peter F
Producer: 20101108
In:
Journal of clinical pharmacology vol. 50
Availability: No items available.
|
|
329.
|
|
|
330.
|
|
|
331.
|
Midazolam Limited Sampling Strategy With a Population Pharmacokinetic Approach to Simultaneously Estimate Cytochrome P450 (CYP) 3A Constitutive, Inhibition, and Induction/Activation Conditions in Healthy Adults. [electronic resource] by
- Yang, Jincheng
- Nikanjam, Mina
- Capparelli, Edmund V
- Tsunoda, Shirley M
- Greenberg, Howard E
- Penzak, Scott R
- Stoch, S Aubrey
- Bertino, Joseph S
- Nafziger, Anne N
- Ma, Joseph D
Producer: 20200929
In:
Journal of clinical pharmacology vol. 59
Availability: No items available.
|
|
332.
|
|
|
333.
|
|
|
334.
|
|
|
335.
|
|
|
336.
|
|
|
337.
|
|
|
338.
|
|
|
339.
|
Doravirine and the Potential for CYP3A-Mediated Drug-Drug Interactions. [electronic resource] by
- Khalilieh, Sauzanne G
- Yee, Ka Lai
- Sanchez, Rosa I
- Fan, Li
- Anderson, Matt S
- Sura, Monali
- Laethem, Tine
- Rasmussen, Scott
- van Bortel, Luc
- van Lancker, Griet
- Iwamoto, Marian
Producer: 20200330
In:
Antimicrobial agents and chemotherapy vol. 63
Availability: No items available.
|
|
340.
|
|